SPRY4 expression levels were higher than those of SPRY4-IT1 in yolk sac tumour, embryonal carcinoma, and choriocarcinoma, whereas SPRY4-IT1 expression levels were higher than those of SPRY4 in teratoma. Here, SPRY4 is linked to embryonal carcinoma.